Sera Prognostics, Inc. (SERA)
NASDAQ: SERA · Real-Time Price · USD
2.050
-0.150 (-6.82%)
Jul 17, 2026, 4:00 PM EDT - Market closed
Sera Prognostics Market Cap
Sera Prognostics has a market cap or net worth of $80.28 million as of July 17, 2026. Its market cap has decreased by -28.25% in one year.
Market Cap
80.28M
Enterprise Value
-3.99M
1-Year Change
-28.25%
Ranking
Category
Stock Price
$2.05
ChartMarket Cap Chart
Since the IPO on July 15, 2021, Sera Prognostics's market cap has decreased from $488.14M to $80.28M, a decrease of -83.55%. That is a compound annual growth rate of -30.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 80.28M | -29.49% |
| Dec 31, 2025 | 113.85M | -58.58% |
| Dec 31, 2024 | 274.91M | 46.70% |
| Dec 29, 2023 | 187.39M | 379.49% |
| Dec 30, 2022 | 39.08M | -81.47% |
| Dec 31, 2021 | 210.90M | -56.79% |
| Jul 15, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neuronetics | 123.87M |
| Rapid Micro Biosystems | 103.29M |
| Hyperfine | 97.49M |
| Outset Medical | 80.82M |
| Nano-X Imaging | 72.38M |
| LENSAR | 69.64M |
| Xtant Medical Holdings | 62.14M |
| Pulmonx | 61.24M |